GHA
SNY icon

GW Henssler & Associates’s Sanofi SNY Stock Holding History

GW Henssler & Associates’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-152,386
Closed -$7.58M – 175
2023
Q4 		$7.58M Sell
152,386
-1,219
-0.8% -$59.6K 0.5% 64
2023
Q3 		$8.24M Sell
153,605
-1,554
-1% -$82.9K 0.56% 62
2023
Q2 		$8.36M Buy
155,159
+531
+0.3% +$28.6K 0.55% 62
2023
Q1 		$8.41M Buy
154,628
+1,415
+0.9% +$68.8K 0.56% 61
2022
Q4 		$7.42M Buy
153,213
+1,730
+1% +$75.9K 0.52% 62
2022
Q3 		$5.76M Buy
151,483
+2,720
+2% +$121K 0.43% 67
2022
Q2 		$7.44M Buy
148,763
+565
+0.4% +$30K 0.55% 61
2022
Q1 		$7.61M Buy
148,198
+2,794
+2% +$144K 0.46% 68
2021
Q4 		$7.29M Buy
145,404
+920
+0.6% +$45.5K 0.46% 67
2021
Q3 		$6.97M Sell
144,484
-9,708
-6% -$494K 0.48% 71
2021
Q2 		$8.12M Buy
154,192
+2,387
+2% +$125K 0.53% 67
2021
Q1 		$7.51M Buy
151,805
+4,305
+3% +$207K 0.54% 66
2020
Q4 		$7.17M Buy
147,500
+520
+0.4% +$25.6K 0.55% 63
2020
Q3 		$7.37M Sell
146,980
-1,807
-1% -$93K 0.63% 61
2020
Q2 		$7.6M Sell
148,787
-3,463
-2% -$168K 0.67% 58
2020
Q1 		$6.66M Sell
152,250
-3,301
-2% -$158K 0.67% 56
2019
Q4 		$7.81M Buy
155,551
+5,229
+3% +$245K 0.65% 61
2019
Q3 		$6.96M Buy
150,322
+3,699
+3% +$160K 0.62% 61
2019
Q2 		$6.34M Buy
146,623
+2,049
+1% +$87.1K 0.57% 62
2019
Q1 		$6.4M Buy
+144,574
New +$6.19M 0.59% 62
2014
Q4 		– Sell
-6,810
Closed -$384K – 169
2014
Q3 		$384K Sell
6,810
-416
-6% -$22.3K 0.05% 116
2014
Q2 		$384K Sell
7,226
-6,544
-48% -$347K 0.05% 116
2014
Q1 		$720K Sell
13,770
-7,945
-37% -$402K 0.08% 108
2013
Q4 		$1.17M Sell
21,715
-305
-1% -$15.7K 0.14% 95
2013
Q3 		$1.11M Sell
22,020
-1,432
-6% -$72.9K 0.14% 93
2013
Q2 		$1.21M Buy
+23,452
New +$1.25M 0.17% 91

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

GW Henssler & Associates's SNY Position: Q1 2024 in Review

GW Henssler & Associates sold out of Sanofi (SNY) in Q1 2024, closing a stake of 152,386 shares — an estimated $7.58M sold.

GW Henssler & Associates first reported a position in SNY in Q2 2013 and held it in 26 quarters. The position peaked at $8.41M in Q1 2023. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

  • GW Henssler & Associates reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
  • GW Henssler & Associates sold 152,386 Sanofi shares in Q1 2024, an estimated $7.58M.
  • GW Henssler & Associates first reported a position in Sanofi in Q2 2013 and held it in 26 quarters.
  • GW Henssler & Associates's Sanofi position peaked at $8.41M in Q1 2023.
  • 713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on GW Henssler & Associates's 13F filing for Q1 2024, filed 7 May 2024.